CAS 211439-12-2

L-Glutamine,L-asparaginyl-L-alanyl-L-prolyl-L-valyl-L-seryl-L-isoleucyl-L-prolyl-

Description:

The chemical substance with the name "L-Glutamine, L-asparaginyl-L-alanyl-L-prolyl-L-valyl-L-seryl-L-isoleucyl-L-prolyl-" and CAS number 211439-12-2 is a peptide composed of multiple amino acids, specifically L-glutamine and several other L-amino acids. This compound is characterized by its structure, which includes a sequence of amino acids linked by peptide bonds, contributing to its potential biological activity. Peptides like this one can play significant roles in various physiological processes, including protein synthesis, cellular signaling, and metabolic regulation. The presence of multiple L-amino acids suggests that this peptide may exhibit specific conformational properties, influencing its stability and interactions with biological targets. Additionally, the sequence of amino acids can determine the peptide's solubility, reactivity, and overall functionality in biological systems. Such compounds are often studied for their therapeutic potential, including applications in nutrition, medicine, and biochemistry. However, detailed studies would be necessary to fully understand its specific properties and potential uses.

Formula: C₃₆H₆₀N₁₀O₁₂

L-Asparaginyl-L-alanyl-L-prolyl-L-valyl-L-seryl-L-isoleucyl-L-prolyl-L-glutamine

CAS: 211439-12-2

Formula: C₃₆H₆₀N₁₀O₁₂

Purity: 97%

Color and Shape: Solid

Molecular weight: 824.9214

Ref: IN-DA01CP91

Davunetide

CAS: 211439-12-2

Davunetide: neuroprotective 8-amino acid peptide, improves daily function in schizophrenia, boosts memory in mild cognitive impairment.

Formula: C₃₆H₆₀N₁₀O₁₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 824.92

Ref: TM-T21470

NAP

CAS: 211439-12-2

NAP is a neuroprotective peptide, which is derived from activity-dependent neuroprotective protein (ADNP), with a mechanism involving microtubule stabilization and neuronal protection. It exhibits the ability to protect neurons from various types of damage, including oxidative stress and conditions mimicking neurodegenerative diseases. NAP enhances axonal transport and increases the resilience of neurons to insults that would typically result in cell death. This peptide has shown promise in preclinical studies for its potential to halt or reverse cognitive decline, making it a focal point for research into therapeutic strategies for disorders like Alzheimer's disease and other tauopathies. The peptide operates by binding to microtubules, promoting stability, and facilitating efficient transport of cellular components. Studies have highlighted its role in traversing the blood-brain barrier, which makes it a viable candidate for central nervous system-targeted therapies. Researchers continue to explore its efficacy and possible applications in improving cognitive function and providing neuroprotection in aging populations.

Purity: (Hplc-Ms) Min. 98 Area-%

Ref: 3D-BN172353

NAP

CAS: 211439-12-2

NAP is a potent, selective and orally bioavailable inhibitor of bacterial nitrate reductase. It has been shown to have broad-spectrum activity against Gram-positive and Gram-negative bacteria. NAP inhibits the synthesis of DNA, which is essential for the bacterial cell cycle. It binds to the active site of the enzyme, thereby inhibiting the reduction of nitrite to nitric oxide. NAP also displays high selectivity for bacteria with respect to mammalian cells. This agent has been shown to be effective in treating bowel disease by reducing nitrate levels in the gut, as well as in models of neuronal death caused by cerebral ischemia.

Formula: C₃₆H₆₀N₁₀O₁₂

Purity: (Hplc-Ms) Min. 98 Area-%

Molecular weight: 824.93 g/mol

Ref: 3D-J-013876